Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Role of Estrogen in the Neurobiology of Eating Disorders
Sponsor: Massachusetts General Hospital
Summary
This is a randomized, double blind, placebo-controlled study of the effects of transdermal estradiol versus placebo on cognitive flexibility, reward processing, and eating disorder pathology in hypoestrogenemic female adolescents and young adults (ages 14-35 years) with an eating disorder characterized by extreme dietary restriction and/or excessive exercise. Subjects will be randomized 1:1 to 12 weeks of transdermal estradiol with cyclic progesterone or placebo patches and cyclic placebo pills. Study visits include a screening visit to determine eligibility and visits at baseline, 8 weeks, and 12 weeks. Study procedures comprise behavioral, neuroimaging, and endocrine assessments.
Official title: The Role of Estrogen in the Neurobiology of Eating Disorders: A Study of Cognitive Flexibility and Reward in Eating Disorders
Key Details
Gender
FEMALE
Age Range
14 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2019-06-13
Completion Date
2026-12-31
Last Updated
2025-05-06
Healthy Volunteers
No
Conditions
Interventions
17-β estradiol transdermal patches with cyclic progesterone
17-β estradiol transdermal patches (100 mcg 17-β estradiol/day) with cyclic progesterone (200 mg micronized progesterone daily for 12 days every month)
Placebo patch and pill
Placebo patch and pill
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States